DUTREBIS FDA approval date

The FDA approved DUTREBIS on 6 Feb 2015.

FDA approval date
6 Feb 2015

Drug identity has not yet been verified against registry records

Also recorded as LAMIVUDINE; RALTEGRAVIR POTASSIUM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-02-06DayDUTREBISFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206510", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["DUTREBIS"], "active_ingredients": ["LAMIVUDINE", "RALTEGRAVIR POTASSIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150206", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026